SARS-CoV-2 associated cardiac abnormalities in elite athletes: results from the prospective, longitudinal COMMIT cohort presentation at ESC Preventive Cardiology 2022

Back

EAPC Premium Access

SARS-CoV-2 associated cardiac abnormalities in elite athletes: results from the prospective, longitudinal COMMIT cohort

Session: Young Investigators Award Sports Cardiology and Exercise

Topic: Pre-Competition Screening and Sports Eligibility

Speaker: Miss J. Van Hattum (Amsterdam, NL)

Event: ESC Preventive Cardiology 2022

Congress Presentation

About the speaker

Miss Juliette Van Hattum

Amsterdam University Medical Centre, Amsterdam (Netherlands (The))

0 follower

5 more presentations in this session

The prevalence and clinical significance of a reduced ventricular ejection fraction in asymptomatic young elite endurance athletes

Speaker: Doctor R. De Bosscher (Leuven, BE)

SARS-CoV-2 infection and return-to-play in junior competitive athletes: is systematic cardiac screening needed?

Speaker: Doctor L. Cavigli (Siena, IT)

Left ventricle myocardial deformation in olympic athletes assessed by cardiac magnetic resonance: does the sex and discipline matter?

Speaker: Doctor S. Monosilio (Rome, IT)

What is the association between lifelong exercise volumes, valvular function and aortic diameters in subjects with a bicuspid aortic valve?

Speaker: Miss B. Schreurs (Nijmegen, NL)

Positive CMR findings are associated with polymorphic ventricle arrhythmias and ECG repolarization changes but not with exercises induced arrhythmias in competitive and non-competitive athletes

Speaker: Doctor P. MARCO (Rome, IT)

Access the full session

Young Investigators Award Sports Cardiology and Exercise

Speakers: Miss J. Van Hattum, Doctor R. De Bosscher, Doctor L. Cavigli, Doctor S. Monosilio, Miss B. Schreurs...

Access

Video

About the event

ESC Preventive Cardiology 2022

7 April - 9 April 2022

Sessions Presentations

Congress

Enthusiasm vs. evidence for COVID-19 pharmacotherapies: what do we know and what have we learnt? – discussion.

29 August 2021

ESC Premium Access

Preventing and managing COVID-19: where are we? - Chat Moderator.

29 August 2021

ESC Premium Access

Great Debate: antithrombotic therapeutic dilemmas in PAD – dual antiplatelet or dual-pathway antithrombotic therapy? – discussion.

29 August 2021

SARS-CoV-2 associated cardiac abnormalities in elite athletes: results from the prospective, longitudinal COMMIT cohort

About the speaker

Miss Juliette Van Hattum

5 more presentations in this session

The prevalence and clinical significance of a reduced ventricular ejection fraction in asymptomatic young elite endurance athletes

SARS-CoV-2 infection and return-to-play in junior competitive athletes: is systematic cardiac screening needed?

Left ventricle myocardial deformation in olympic athletes assessed by cardiac magnetic resonance: does the sex and discipline matter?

What is the association between lifelong exercise volumes, valvular function and aortic diameters in subjects with a bicuspid aortic valve?

Positive CMR findings are associated with polymorphic ventricle arrhythmias and ECG repolarization changes but not with exercises induced arrhythmias in competitive and non-competitive athletes

Access the full session

Young Investigators Award Sports Cardiology and Exercise

About the event

ESC Preventive Cardiology 2022

Related content

Enthusiasm vs. evidence for COVID-19 pharmacotherapies: what do we know and what have we learnt? – discussion.

Preventing and managing COVID-19: where are we? - Chat Moderator.

Great Debate: antithrombotic therapeutic dilemmas in PAD – dual antiplatelet or dual-pathway antithrombotic therapy? – discussion.

ESC 365 is supported by